Ethambutol HCl
Bacteriostatic agent supplied as hydrochloride salt — USP/EP/BP grade — for oral tablet formulation manufacturing. Sourced for first-line tuberculosis combination therapy product lines.
Pharmaceutical & Life Science Solutions
First and second-line TB APIs targeting Mycobacterium tuberculosis bactericidal pathways. Supplied in USP/EP/BP/IP grade for DOTS and drug-resistant tuberculosis combination therapy manufacturing.
Bacteriostatic agent supplied as hydrochloride salt — USP/EP/BP grade — for oral tablet formulation manufacturing. Sourced for first-line tuberculosis combination therapy product lines.
Bactericidal prodrug in USP/EP/BP/JP/IP grade for oral tablet and injectable formulation manufacturing. Cornerstone first-line agent sourced for DOTS tuberculosis therapy product lines.
Nicotinamide analogue sterilising agent in USP/EP/BP/IP grade for oral tablet formulation manufacturing. Sourced for intensive-phase first-line tuberculosis combination therapy product lines.
Rifamycin RNA polymerase inhibitor in USP/EP/BP/IP grade for oral capsule and IV injectable formulation manufacturing. Cornerstone first-line agent across all tuberculosis treatment regimens.
Cycloserine derivative second-line agent in pharmaceutical grade for oral tablet formulation manufacturing. Sourced for multi-drug-resistant tuberculosis (MDR-TB) combination therapy product lines.